Biomedicines—Moving Biologic Agents into Approved Treatment Options
نویسندگان
چکیده
منابع مشابه
Biomedicines—Moving Biologic Agents into Approved Treatment Options
The development of biologic agents for therapeutic purposes, or biomedicines, has seen an active area of research both at the bench and in clinical trials. There is mounting evidence that biologic products can provide effective therapy for diseases that have been unresponsive to traditional pharmacologic approaches. Monoclonal antibody therapy for cancer and rheumatologic diseases has become a ...
متن کاملPsoriatic arthritis: treatment strategies using biologic agents.
The traditional management of psoriatic arthritis (PsA) includes NSAIDs, corticosteroids and DMARDs. Advancement in the knowledge of the immunopathogenesis of PsA has been associated with the development of biologic agents which have revolutionized the management of the disease. Among biologics drugs, there are the 4 currently available anti-TNFα blocking agents (etanercept, infliximab, adalimu...
متن کاملSecond-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents.
Standard first-line treatment for metastatic castration-resistant prostate cancer (mCRPC) is docetaxel plus prednisone; however, patients will usually experience disease progression during or after docetaxel treatment due to inherent or acquired resistance. Before 2010, second-line options for mCRPC were limited. However, cabazitaxel, abiraterone acetate and enzalutamide have since been approve...
متن کاملNew agents approved for treatment of acute staphylococcal skin infections
Vancomycin has been a predominant treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections for decades. However, growing reservations about its efficacy led to an urgent need for new antibiotics effective against MRSA and other drug-resistant Staphylococcus aureus strains. This review covers three new anti-MRSA antibiotics that have been recently approved by the FDA: dalbavan...
متن کاملTreatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center.
Treatment Options for Pityriasis Rubra Pilaris Including Biologic Agents: A Retrospective Analysis From anAcademicMedical Center Pityriasis rubra pilaris (PRP) is characterized by hyperkeratoticpapules,palmoplantarkeratoderma, andwidespreaderythema with islands of sparing. Treatment is challenging, and a standard therapeutic protocol doesnot exist. Given thepaucity of available therapeutic data...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomedicines
سال: 2013
ISSN: 2227-9059
DOI: 10.3390/biomedicines1010001